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ALG-2 (a gene product of PDCD6) is a 22-kD protein containing five serially repetitive EF-hand structures and belongs to the 
penta-EF-hand (PEF) family, including the subunits of typical calpains. ALG-2 is the most conserved protein among the PEF 
family members and its homologs are widely found in eukaryotes. X-ray crystal structures of various PEF proteins including 
ALG-2 have common features: presence of eight α-helices and dimer formation via paired EF5s that are positioned in      
anti-parallel orientation. ALG-2 forms a homodimer and a heterodimer with its closest paralog peflin. Like calmodulin, a 
well-known four-EF-hand protein, ALG-2 interacts with various proteins in a Ca2+-dependent fashion, but the binding motifs 
are completely different. With some exceptions, ALG-2-interacting proteins commonly contain Pro-rich regions, and ALG-2 
recognizes at least two distinct Pro-containing motifs: PPYP(X)nYP (X, variable; n=4 in ALIX and PLSCR3) and PXPGF 
(represented by Sec31A). A shorter alternatively spliced isoform, lacking two residues and designated ALG-2∆GF122, does not 
bind ALIX but maintains binding capacity to Sec31A. X-ray crystal structural analyses have revealed that binding of calcium 
ions induces the configuration of the side chain of R125 so that it opens Pocket 1, which accepts PPYP, but Pocket 1 remains 
closed in the case of ALG-2∆GF122. ALG-2 dimer has two ligand-binding sites, each in a monomer molecule, and appears to 
function as a Ca2+-dependent adaptor protein to either stabilize a preformed complex or to bridge two proteins on scaffolds in 
systems of the endosomal sorting complex required for transport (ESCRT) and ER-to-Golgi transport. 
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1  Introduction: penta-EF-hand (PEF) family 
1.1  Discovery of PEF domain in calpain 
Calpains are non-lysosomal intracellular cysteine protein-
ases. Typical calpains such as μ-calpain (calpain-1) and 
m-calpain (calpain-2) are ubiquitously expressed in mam-
malian tissues and are activated by micromolar and milli-
molar levels of Ca2+, respectively, in in vitro protease assays. 
Molecular cloning of cDNAs for the large catalytic subunit 
(80 kD) and the small regulatory subunit (30 kD) revealed 
the presence of four serially repetitive EF-hands (he-
lix-loop-helix Ca2+-binding motifs) in the C-terminal region 
of calpain [1,2], and the Ca2+-binding domain was called 
calmodulin domain for more than a decade.  
In 1997, Cygler’s group and Narayana’s group including 
Maki independently determined the 3D structures of the rat 
and pig calpain small subunits by X-ray crystallography 
[3,4]. Surprisingly, the small subunits were found to possess 
five, not four, EF-hand structures, and the C-terminal fifth 
EF-hand (EF5) paired up with one from another molecule to  
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form a dimer as if EF-hands embrace [5]. In a canonical 
EF-hand, the calcium ion has a pentagonal bipyramidal co-
ordination (five ligands on the yz plane and two ligands in 
the x axis), and canonical metal coordination positions are 
occupied by seven liganding oxygen atoms from the side 
chain (x, y, z, and bidentate -z), peptide carbonyl (-y) and 
water (-x) in the Ca2+-binding loop (see [6,7] for reviews). 
However, the newly assigned EF-hand 1 (EF1) lacks one 
residue in the loop and has a few amino acid substitutions. 
At the first Ca2+-coordinating position in the loop (x), EF1 
binds Ca2+ by coordinating with the carbonyl oxygen of the 
peptide bond of Ala in place of the side-chain oxygen of the 
canonical Asp. The C-terminal region of the calpain large 
subunit has similar structures, and each EF5 of the large and 
small subunits pairs to form a calpain heterodimer [8,9]. We 
proposed the name “penta-EF-hand (PEF)” to indicate a 
domain found in a group of proteins that possess serially 
repetitive five EF-hand sequences [10]. 
1.2  Finding of apoptosis-linked gene 2 (ALG-2) as a 
PEF protein 
ALG-2 was one of the six apoptosis-linked genes whose 
cDNA clones were isolated by the “death-trap” method in 
which a cDNA library constructed in a mammalian expres-
sion vector was used to transfect mouse T cell hybridoma 
3DO cells in order to protect them from death induced by T 
cell receptor stimulation [11]. The obtained ALG-2 cDNA 
clone turned out to be an anti-sense transcript, and its pro-
tective effects were found to be due to depletion of ALG-2, 
indicating, in other words, that ALG-2 functions as a 
pro-apoptotic factor [12]. Vito et al. [11] reported that the 
ALG-2 molecule possesses two canonical EF-hand se-
quences and demonstrated its Ca2+- binding capacity by a 
45Ca2+-ligand blotting (overlay) experiment. A part of the 
isolated full-length ALG-2 cDNA was identical to a previ-
ously reported partial cDNA clone named pMP41 encoding 
a putative Ca2+-binding protein [13]. We noticed that 
ALG-2 also contains five EF-hand motifs based on compar-
ison with the amino acid sequences of the C-terminal re-
gions of calpains [10].  
1.3  Evolution of PEF family 
In addition to calpains and ALG-2, sorcin [14,15], grancal-
cin [16] and peflin [17,18] belong to the PEF family in 
mammals [19]. Based on the differences in primary struc-
tures of the EF1 Ca2+-binding loops, mammalian PEF pro-
teins are classified into two groups: Group I (ALG-2 and 
peflin) and Group II (calpain subfamily members, sorcin 
and grancalcin). Sorcin is more similar to grancalcin than to 
calpain subfamily members. EF1s of Group II proteins 
commonly have a substitution at the Ca2+-coordinating po-
sition x from Asp to Ala and lack one residue in the 
Ca2+-binding loop. 
A closer evolutional relation between sorcin/grancalcin 
and the calpain subfamily than between sorcin/grancalcin 
and ALG-2 is supported by the fact that positions of introns 
are well-conserved among sorcin, grancalcin and calpains 
but that conservation is limited when intron positions are 
compared between ALG-2 and calpains [19]. Interestingly, 
however, phylogenetic analyses based on primary structures 
have indicated a slightly closer relation of the ALG-2/peflin 
subfamily to the sorcin/grancalcin subfamily than to the 
calpain subfamily among all human PEF proteins. This 
causes erroneous annotation of some PEF proteins in pro-
tein sequence databases such as UnitProtKB (http://www. 
uniprot.org/help/uniprotkb). The sequence of Schistosoma 
japonicum sorcin (UniProtKB accession code: Q94743) 
actually corresponds to ALG-2 as evidenced by a high con-
servation of the EF1 sequence. The sequence of Zea mays 
grancalcin (UniProtKB accession code: B6SNX9) is more 
similar to the sequence of Group I PEF proteins in the EF1 
sequence, indicating that naming this protein grancalcin is 
not appropriate. Homologs of PEF I genes have been found 
in lower animals, plants, fungi and protists. Neither sorcin 
nor PEF-containing calpains have been found in fungi, sug-
gesting divergence of the ALG-2/sorcin/calpain clan in the 
animal kingdom [19]. In other words, ancestral ALG-2 is a 
prototype of PEF proteins in eukaryotes. 
Although the lengths of N-terminal tails of ALG-2 pro-
teins are variable (human, 23 aa; chicken, 10 aa; zebra fish, 
17 aa; fruit fly, 8 aa), ALG-2 is relatively conserved in ani-
mals (69% and 89% identities between humans and fruit fly 
and between humans and zebra fish, respectively, in the 
PEF domain of human ALG-2, residues No. 24−191). There 
are two amino acid substitutions between human and mouse 
ALG-2 (residue No. 12: Ala in humans vs. Gly in mouse; 
residue No. 46: Thr in humans vs. Asn in mouse).  
2  Structural analyses of ALG-2 
2.1  Biochemical properties 
Taking advantage of a Ca2+-dependent aggregation-prone 
property of ALG-2 at a high protein concentration, recom-
binant untagged ALG-2 protein (22 kD) can be successfully 
produced in Escherichia coli and can be easily purified by 
precipitation with addition of Ca2+ to cell lysates and ex-
traction of the pellets with a calcium chelator [20]. The par-
tially purified protein is further purified by ion exchange 
chromatography followed by gel filtration. In contrast to 
sorcin and grancalcin, ALG-2 does not form a stable dimer. 
Ca2+-free ALG-2 is eluted at the positions of a monomer or 
slightly larger molecule in the gel filtration [20,21]. How-
ever, results of chemical cross-linking experiments in vitro 
[21] and in vivo [22] suggest the presence of ALG-2 as a 
dimer. Analytical ultracentrifugation analysis suggests that 
ALG-2 exists predominantly in a dimer form at higher pro-
tein concentrations (5−20 μmol L−1) but in equilibrium be-
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tween a monomer and a dimer at protein concentrations less 
than 1 μmol L−1 [22].  
Dissociation constants of Ca2+ at two high-affinity bind-
ing sites (KD ~2 μmol L−1) and one low-affinity binding site 
(KD ~300 μmol L−1) were estimated by the flow dialysis 
method in the presence of 0.5% Tween 20 [22,23]. When 
compared with the canonical EF-hand motifs, EF1 and EF3 
have sequences that are more conserved than those of EF2, 
EF4 and EF5 [20]. Analyses of amino acid-substituted mu-
tants of Ca2+-coordinating residues at -z positions of EF1 
(E47A or E47D), EF3 (E114A or E114D) and EF1/EF3 
(E47A/E114 A) revealed strong Ca2+-binding sites located 
at EF1 and EF3 [21,22].  
Fluorometric analyses using either a fluorescent hydro-
phobic probe, 2-(p-toluidino)naphthalene-6-sulfonate (TNS), 
or intrinsic fluorescence of tryptophan revealed that binding 
to Ca2+ induces conformational changes and exposure of 
hydrophobic surfaces at a micromolar Ca2+ concentration 
[20−22]. These biochemical properties agree with those of 
Ca2+-sensing EF-hand proteins such as calmodulin [24,25].  
2.2  X-ray crystal structures 
Crystals of recombinant ALG-2 proteins were prepared by 
three independent groups [26−29], and 3D structures were 
resolved successfully from some of the crystals. The solved 
structures have the following features common to all PEF 
proteins whose structures have been solved. (i) Eight 
α-helices instead of ten α-helices are present as schematically 
illustrated for human ALG-2 in Figure 1. Helices α4 and α7 
are shared by neighboring EF-hands (α4, EF2 and EF3; α7,  
 
 
Figure 1  Schematic structures of human ALG-2 proteins and genomic 
DNA. Alternative splicing at the donor site of Exon 4 generates a 
six-nucleotide (underlined) shorter mRNA encoding the two-amino acid 
(Gly121Phe122)-deleted isoform of ALG-2 (designated ALG-2∆GF122). Five 
EF-hands (EF1−EF5) are made up of eight α-helices (α1−α8). SD, splicing 
donor site; SD′, alternative SD. Open boxes and closed boxes in the sche-
matic genomic DNA structure indicate exons encoding untranslated and 
translated regions, respectively. Nucleotides shown in upper and lower  
cases indicate exon and intron sequences, respectively. 
EF4 and EF5). (ii) Dimerization occurs by pairing of each 
isolated EF5. An anti-parallel β-sheet structure is formed 
between the two EF5s. (iii) Although the overall structure of 
the region ranging from EF1 to EF4 resembles the structure 
of calmodulin, it is more compact due to the shortness of the 
central helix connecting EF2 and EF3 (α4) in seven residues 
(corresponding to two turns in the helix) (Figure 2).  
Jia et al. [26] crystallized the Ca2+-bound form of mouse 
des1-20ALG-2 with a buffer containing polyethylene glycol 
(PEG) 8000 after treatment of full-length recombinant 
ALG-2 with elastase. They found a continuous electron 
density in a hydrophobic groove in the solved ALG-2 
structure and interpreted it as a Gly/Pro-rich decapeptide 
derived from the cleaved N-terminus. We also crystallized 
the Ca2+-bound form of human ALG-2 in the presence of 
PEG8000 but with genetically engineered N-terminally 
truncated des3-20ALG-2. Surprisingly, we also observed an 
electron density in a similar hydrophobic groove [28]. The 
Ca2+-bound form of des3-23ALG-2 crystallized under dif-
ferent conditions in the absence of PEG8000 showed no 
such electron density there [29], and it is concluded that a 
part of the PEG8000 molecule occupied the hydrophobic 
groove.  
In contrast to Group II PEF proteins such as calpain, 
ALG-2 is unique in that its EF5 binds Ca2+. Lack of coordi-
nation by bidentate carboxyl oxygen atoms at the -z position, 
however, suggests that EF5 has only a weak Ca2+-binding 
capacity and that Ca2+-binding at this site is non-physiolo- 
gical in the cell. Differences between the 3D structures of 
the Ca2+-free form and Ca2+-bound form of ALG-2 are 
small, though an anti-parallel β-sheet structure is absent in 
the Ca2+-free form of ALG-2 [28]. Zinc ions bind to EF1 
and EF3 at a coordination similar to that of calcium ions. 
2.3  Comparison of ALG-2 and other PEF proteins  
When the dimeric structure of ALG-2 is compared with the  
 
 
Figure 2  Comparison of the structures of calmodulin and ALG-2 mono-
mer. Figures of 3D structures shown in ribbon representation were gener-
ated with PyMol using data deposited in the Protein Data Bank (PDB codes: 
calmodulin, 1cll; ALG-2, 2zn9). Helices from EF1 to EF4 (in both cal-
modulin and ALG-2) and those in EF5 (only in ALG-2) are shown in cyan 
and in green, respectively. Loops and β-sheet structures are colored in pale 
pink and magenta, respectively. EF-hand coordinated calcium atoms are 
shown as gray spheres. Distances between two calcium atoms in EF1 and  
EF3 are indicated. 
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dimeric structures of Group II PEF proteins (grancalcin, 
sorcin and calpain small subunit), two differences become 
apparent in overall structures as shown in Figure 3: (i) 
When anti-parallel β-sheet-containing loops of EF5s (red) 
are placed horizontally and 3D structures are projected onto 
the paper surface (X-Y plane, top view), the relative posi-
tions of EF1s (blue) to the anti-parallel loops are rotated 
clockwise more in ALG-2, and (ii) the ALG-2 dimer has a 
larger crevice and smaller interacting surface (side view), 
possibly being the reason for the aforementioned weaker 
dimer formation ability than that of Group II PEF proteins. 
2.4  Isoforms 
An isoform of ALG-2 was first reported in the mouse [23]. 
The isolated cDNA clone designated ALG-2,1 was shorter 
in six nucleotides corresponding to the two amino acids 
Gly121Phe122 in comparison with the full-length cDNA clone 
ALG-2,5. Both transcripts were present in mouse tissues at 
an approximate ratio of 2:1 (ALG-2,5 vs. ALG-2,1). The 
same type of isoform lacking 121-GF-122 (designated as 
ALG-2∆GF122 in this article; non-deleted ALG-2 being re-
garded as wild type for convenience) is also registered in 
human DNA databases, such as GenBank under accession 
No. BC110291.1. Since Gly121Phe122 is immediately fol-
lowed by Gly123 in the amino acid sequence, the deletion of 
Phe122Gly123 is assigned in the results of BLAST searches 
using the blastp or tblastn program. In the nucleotide se-
quence of cDNAs, however, the deletion occurs in 
GGTTTC (Gly121Phe122) but not in TTCGGC (Phe122Gly123)  
 
 
Figure 3  Structural comparison among mammalian PEF proteins. Di-
meric structures of PEF domains are shown in ribbon representation. 
Symmetric two-fold axes are perpendicular to the paper surface in top view 
that shows anti-parallel β-sheets of EF5s in red. Arrows indicate orienta- 
tion of the side view. PDB codes are indicated in parentheses. 
in the sequence of TCAGGTTTCGGCTAC (corresponding 
to 120-SGFGY-124).  
In the current human EST database, the ratio of retrieved 
human ALG-2 cDNAs containing nucleotides correspond-
ing to 121-GF-122 and those lacking the corresponding 
hexanucleotides is approximately 3:1. Analysis of the hu-
man genome database revealed that the ALG-2 gene (sym-
bol, PDCD6; location, 5pter-p15.2) has six exons and that 
the boundary sequence of Exon 4 and Intron 4 contains an 
alternative splicing donor site (TCAGGTTTCGgtaactcactca: 
lower case, intron sequence; underlined sequence, missing 
by alternative splicing) (Figure 1). The shorter isoform has a 
lower Ca2+-sensitivity [23].  
3  Interacting proteins 
3.1  Peflin 
Peflin, a 30-kD PEF protein with a long N-terminal hydro-
phobic domain, was found as the closest paralog of human 
ALG-2 [17]. The N-terminal tail has nine repeats of 
nonapeptide (A/PPGGPYGGP). Orthologs are found in 
vertebrates and the fruit fly Drosophila but not in the nem-
atode Caenorhabditis elegans. While ALG-2 exists both as 
a heterodimer with peflin and as a homodimer in the cell, 
peflin exists only as a heterodimer with ALG-2 [18]. The 
heterodimerization occurs through their EF5s [30]. The het-
erodimer formed between peflin and ALG-2 dissociates in 
the presence of Ca2+ [18], probably due to binding of Ca2+ 
to EF5 of ALG-2 at a high Ca2+ concentration. Pe-
flin/ALG-2 heterodimer may be stable under physiological 
conditions. However, soluble recombinant proteins of peflin 
are not yet available, and knowledge of biochemical proper-
ties and functions is limited.  
3.2  Ca2+-dependent interaction 
ALG-2 functions as a Ca2+ sensor by changing its confor-
mation in a Ca2+-dependent manner at the micromolar level 
of Ca2+ as described above. This conformational change 
enables ALG-2 to interact with various proteins. ALIX 
(ALG-2-interacing protein X, also named AIP1) was the 
first protein that was shown to interact with ALG-2 in a 
Ca2+-dependent fashion [31,32]. The C-terminal region 
containing a Pro-rich sequence was shown to be essential 
for the binding. Subsequently, annexin A11 (previously 
designated as annexin XI) and annexin A7 (annexin VII) 
were shown to interact with ALG-2 [33,34]. The N-terminal 
regions of these annexins also have Pro-rich sequences. A 
number of ALG-2-interacting proteins have been screened 
by the yeast two-hybrid method and mass-spectrometric 
analyses of products of co-immunoprecipitation or pull-
down with glutathione-S-transferase (GST)-fused ALG-2. 
Combinations of different methods are necessary to further 
validate the interactions of candidate proteins with ALG-2 
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in vitro and/or in vivo. Thus, when searching current pro-
tein-protein interaction databases such as http://string-db. 
org/ and http://www.ebi.ac.uk/intact, results should be 
carefully interpreted. 
A report of interaction of “ALG-2” with Fas/CD95 (one 
of the death receptors) by Jung et al. [35] was sensational 
not only from the viewpoint of potential roles of ALG-2 in 
apoptosis through Fas signaling but also in that there were 
changes in the cellular distribution of “ALG-2” from the 
plasma membrane to cytosol upon Fas stimulation with a 
concomitant limited cleavage of “ALG-2”. However, 
Fas-ALG-2 interaction was later denied by the group of 
Berchtold who clearly demonstrated that the commercially 
available “anti-ALG-2 monoclonal antibody” used by Jung 
et al. [35] did not react with ALG-2 but erroneously reacted 
with the co-chaperone protein p23 [36,37]. Ask1 [38] and 
Raf-1 [39], protein kinases involved in apoptosis and in cell 
signaling, and mucolipin-1 [40], an ion channel involved in 
mucolipidosis, were shown to physically associate with 
ALG-2, but these proteins contain no PRRs. While the 
binding sites were not investigated in the case of Ask1 and 
Raf-1, a region containing 37-EEEDLRRRLKYFF-49 in 
mucolipin-1 was essential for interaction, but the minimal 
binding region requires a neighboring region on either the 
N-terminal or C-terminal side.  
3.3  ALG-2-binding motifs  
An ALG-2-binding site, which was determined by analyses 
of serially deleted and substituted mutants, contains four 
tandem repeats of PXY (X, variable amino acid residue) in 
the PRR of ALIX [41]. By in silico searching for a similar 
PXY sequence in the protein sequence databases, phospho-
lipid scramblase 3 (PLSCR3) became a candidate of a novel 
ALG-2-interacting protein [42]. Unexpectedly, mutational 
analyses revealed that PLSCR3 has two ALG-2-binding 
sites (ABS-1 and ABS-2): one (ABS-1) similar to the 
ALG-2-binding site in ALIX and the other (ABS-2) differ-
ent from that of ALIX. ABS-2 was later found to be similar 
to the ALG-2-binding site of Sec31A [43]. While ALIX and 
ABS-1 of PLSCR3 do not bind the alternatively spliced 
shorter isoform ALG-2∆GF122 [23,42], both Sec31A and 
ABS-2 of PLSCR3 can bind not only ALG-2 but also 
ALG-2∆GF122 [42,44]. An ABS-2-oligopeptide-immobilized 
column was proven to be useful for Ca2+-dependent affinity 
purification of recombinant ALG-2 proteins including 
ALG-2∆GF122 [42]. Comparison of the identified binding 
sequences among ALIX, PLSCR3 and Sec31A revealed two 
consensus core ALG-2-binding motifs  (ABM-1, 
PPYPXXPGYP; ABM-2, PXPGF) (Figure 4). Although the 
exact binding sites are not yet known, several other ALG-2- 
binding proteins also contain sequences rich in Pro, Gly and 
Tyr, such as annexin A7 (4-PGYPPTGYPP-15), annexin A11 
(4-PGYPPPPGGYPP-15), TSG101 (188-CPYPPGGPYPA- 
198) [45], and Scotin (190-PYPMQYPPPYP-200) [46]  
 
Figure 4  Alignment of ALG-2-binding sites in PLSCR3, ALIX and 
Sec31A. Minimal amino sequences sufficient for interaction with ALG-2 
in in vitro binding assays using either synthetic oligopeptides (PLSCR3, 
ALIX) or glutathione-S-transferase (GST)-fused peptides (Sec31A) are 
shown by bars above and below the sequences (purple, PLSCR3; brown, 
ALIX; green, Sec31A). Identical amino acid residues between each pair are 
indicated by closed circles, above which consensus sequences for minimal  
binding (ALG-2-binding motif, ABM) are shown. 
suggesting a consensus sequence of PPYP(X)nYP (X, varia-
ble amino acids, n=3−6). Optimum sequence and number of 
residues between two YPs may depend on surrounding res-
idues. On the other hand, RBM22 [47] has an ABM-2-like 
sequence 373-PPPPPGFGPHMFHPMGPPPP-392, whose 
binding ability remains to be clarified. The effects of amino 
acid substitutions of ALG-2 on ability of binding to target 
proteins are significantly different not only between ABM-1 
type proteins (ALIX, annexin A7, annexin A11 and 
TSG101) and ABM-2 type protein (Sec31A) but also 
slightly different even among ABM-1 type proteins [42,48]. 
Thus, the mode of binding appears to be flexible.  
3.4  Ca2+/EF3-driven arginine switch mechanism 
The structure of the complex between ALG-2 and an ALIX 
oligopeptide was successfully solved at 2.2 Å resolution by 
crystallization of N-terminally truncated ALG-2 (des3- 
23ALG-2) and a 16-residue ALIX oligopeptide (1- 
QGPPYPTYPGYPGYSQ-16, cysteine substituted with ser-
ine) corresponding to ALIX 799-814 in the presence of Zn2+ 
instead of Ca2+ (PDB code: 2zne) [28,49]. The ALIX pep-
tide is seen in a groove that contains two peptide-binding 
hydrophobic pockets (Pockets 1 and 2) in ALG-2 (Figure 5). 
Pocket 1 is formed by residues from the α5-α6 loop and 
those from EF5 (α7 to α8) (Figure 6). Y180 from the other 
ALG-2 molecule in the dimer also constitutes the bottom of 
Pocket 1. Pocket 2 is formed by residues from α3 to α5 in-
cluding F122 and from α7. Polyproline II (PPII) left-handed 
helices are often observed in Pro-rich regions [50], but the 
solved ALIX peptide structure does not form such a PPII 
helix. In vitro binding assays using mutant ALIX peptides 
revealed that 3-PPYP-6, binding to Pocket 1, is the most 
critical segment. Pocket 2 accepts 11-YPG-13 and Q16. 
Among the three YPs, the central 8-YP-9 does not bind to 
the hydrophobic pockets but loops out from the surface of 
Pocket 2, supporting the consensus sequence for ABM-1, 
PPYP(X)nYP, where the number of residues between two 
YPs is variable (n=4, ALIX and PLSCR3).   
The Ca2+ (also Zn2+)-dependent binding of ALG-2 to the  
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Figure 5  3D structure of the complex between ALG-2 and ALIX peptide. 
Two ALIX peptides (stick representation) bind to the ALG-2 dimer (sur-
face representation: Molecule A, largely gray and colored in cyan for 
Pocket 1 and light green for Pocket 2; Molecule B, light yellow; PDB code, 
2zne). Pocket 1 door, R125 in Molecule A, and Y180(B), coming from 
Molecule B and creating a hydrophobic bottom of Pocket 1, are colored in 
blue and orange, respectively. The ALIX peptide bound to Molecule A is 
shown in stick representation in two different colors for carbon atoms: 
magenta, ALG-2-interacting residues; pale pink, non-interacting residues. 
Contact area is enlarged and shown in parallel stereoview. Nitrogen atoms 
and oxygen atoms are also colored in blue and red, respectively, for the 
ALG-2-interacting residues, but they are in the same color (pale pink) as 
carbon atoms in the non-interacting residues. 
ALIX peptide is explained as shown in Figure 6: (i) Binding 
of Ca2+ (or Zn2+) to EF3 causes change in the side chain 
configuration of R125 that is located at the loop connecting 
α5 and α6; (ii) opening of Pocket 1, (iii) entry of the peptide, 
and (iv) re-closure of Pocket 1 by the R125 side chain and  
completion of the peptide trapping. Thus, R125 is a key 
element of the open-close mechanism of Pocket 1 and acts 
as a switch driven by Ca2+/EF3 conformational change. In 
the crystal structure of ALG-2∆GF122 in the Ca2+-bound form 
[48], deletion of the two amino acid residues, 121-GF-122, 
truncates α5 and 120-SGY-122 forms either 310-helix 
(molecule A) or turn and bend (molecule B), affecting con-
figuration of the R123 side chain (corresponding to R125 
in ALG-2WT). A hydrogen bond between a carbonyl oxygen 
atom of S120 (OS120) and guanidino nitrogen atom of R125 
(NH2R125) is observed in the Ca2+-bound form but not in the 
Ca2+-free form of ALG-2WT [28]. A hydrogen bond be-
tween OS120 and NH2R123 is not formed in the Ca2+-bound 
form of ALG-2∆GF122 either [48]. While “R125 door” is 
opened by Ca2+, “R123 door” of the isoform is kept closed. 
Substitution of F122 with alanine does not affect the con-
figuration of R125, and the “R125” door is opened in the 
metal-bound form (Figure 6). Indeed, the mutant ALG- 
2F122A exhibited a stronger ALIX-binding activity. Removal 
of the bulky side chain of F122 created an additional open 
space in Pocket 2 and abolished inter-helix interactions 
with W95 and V98 (present in α4), and α5 inclined away 
from α4 to expand Pocket 2, suggesting acquirement of 
more appropriate positioning of the interacting residues to 
accept the target protein [48]. The structural basis for the 
Ca2+-dependent binding of ALG-2 to ABM-2 peptides re-
mains to be established. Since ALG-2∆GF122 and Y180A 
mutant, incapable of dimerization, maintain the ability for 
binding to Sec31A and PLSCR3, ABM-2 peptides appear 
to bind to a hydrophobic pocket(s) different from at least 
Pocket 1.  
 
 
Figure 6  Model of Ca2+/EF3-driven arginine switch mechanism. In the metal free form of wild-type ALG-2 (designated WT), the flexible side chain of 
R125, located in the loop connecting helices α5 and α6, blocks the mouth of the primary hydrophobic pocket (Pocket 1) and interferes with entry of the tar-
get peptide. Binding of Ca2+ or Zn2+ to EF3 induces a small local movement of helix α5 and relays configuration change of the side chain of R125 forming a 
hydrogen bond with the carbonyl oxygen atom of S120, resulting in opening of Pocket 1 and accepting the ALIX peptide. While the side chain of R123 in 
the Ca2+-bound form of ALG-2∆GF122 (corresponding to R125 of ALG-2) keeps blocking the pocket, Pocket 1 is opened in the Zn2+-bound form of the amino 
acid substitution mutant F122A. PDB codes are indicated in parentheses. Gray fancy ribbons represent α-helices and β-sheets. ALIX peptide is shown by a  
light orange cord. 
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4  Ca2+-dependent adaptor  
4.1  Subcellular localization of ALG-2 
Fluorescence microscopic analyses of ALG-2 using specific 
antibodies have revealed that ALG-2 localizes in both the 
cytoplasm and nucleus in the cell [18,41]. The presence of 
ALG-2 in the nucleus implies certain functions in gene ex-
pression regulation, precursor RNA processing or nuclear 
export of RNAs and/or proteins. RBM22, a nuclear protein 
that contains RNA-binding motif, may work together with 
ALG-2 [47]. It remains unknown whether RBM22 is a ma-
jor target of ALG-2 in the nucleus. Although ALG-2 does 
not bind to liposomes by itself in the presence of Ca2+ in 
vitro, addition of Ca2+ to cell lysates causes translocation of 
ALG-2 to membranous fractions, suggesting binding of 
ALG-2 to membrane-localizing proteins, which reside on 
the membrane either as integral membrane proteins or as 
peripheral proteins recruited to membranes upon stimula-
tion. Since each ALG-2 monomer molecule in the dimer 
accepts one ALIX peptide molecule and the dimer accepts 
two peptides (Figure 5), this stoichiometry raises the pos-
sibility that an ALG-2 dimer links two binding molecules 
and functions as a Ca2+-dependent adaptor protein on the 
membranes or in their vicinity. This adaptor function of 
ALG-2 may be effective for stabilizing two weakly inter-
acting proteins or for bridging two unrelated proteins lo-
calizing together in the vicinity of the membrane or scaf-
folds (Figure 7).  
4.2  Bridging ESCRT-I and ESCRT-III by the ALIX/ 
ALG-2 complex 
Plasma membrane proteins are endocytosed and delivered 
to endosomes, from which they are recycled back to the 
plasma membrane or further transported to lysosomes for 
degradation. Ubiquitinated cargo proteins are sorted on the 
complex required for transport) system, and multivesicular  
 
 
Figure 7  Ca2+-dependent adaptor function of ALG-2. Models of ALG-2 
functioning as a Ca2+-dependent adaptor are illustrated in two cases. A, 
Two ALG-2-binding proteins (a, b) weakly associate with each other, and 
the complex is stabilized by ALG-2 in the presence of Ca2+. B, Two 
ALG-2-binding proteins (c and d) do not associate by themselves but they 
are bridged by ALG-2 on scaffold proteins or membranes that they associ- 
ate with directly or indirectly. 
bodies (MVBs) are formed by the invagination and scission 
of buds from the limiting membrane of the endosome into 
the lumen [51]. Among the four ESCRT complexes, cargoes 
are sequentially recognized by ESCRT-0, -I, and -II, each of 
which contains a different ubiquitin-binding subunit. 
ESCRT-III cleaves the bud necks to form intraluminal vesi-
cles [52]. The ESCRT system also functions in release of 
enveloped RNA virus particles from the plasma membrane 
and scission of two daughter cells at cytokinesis [53,54].  
ALIX is an accessory protein of the ESCRT system [52]. 
While an N-terminally located Bro1 domain of ALIX asso-
ciates with CHMP4 (human ortholog of yeast Snf7, a major 
component of ESCRT-III) [55], the PSAP-sequence in the 
Pro-rich region of ALIX interacts with a UEV domain of 
TSG101 (a ubiquitin- and PTAP-motif-binding subunit of 
ESCRT-I), but this ALIX-TSG101 interaction is weak when 
compared with interaction between the UEV domain and 
HIV-1 p6, containing a PTAP motif, in in vitro binding as-
says using a surface plasmon resonance (SPR) biosensor 
(ALIX peptide 714−723, KD=142 μmol L−1; unubiquitinated 
p6 peptide, KD=27 μmol L−1; ubiquitinated p6 peptide, 
KD=2.3 μmol L−1) [56,57]. Using lysates of cells exoge-
nously expressing Strep-tagged ALIX, endogenous TSG101 
has been shown to be recovered in the pulldown products of 
Strep-ALIX in the presence of Ca2+ but not in the absence 
of Ca2+ [58]. Since ALG-2 directly associates with TSG101 
in a Ca2+-dependent manner [45], ALG-2 was predicted to 
be a Ca2+-dependent factor of ALIX-TSG101 interaction. 
Indeed, we found that the ALG-2-binding site, but not the 
PSAP sequence, in ALIX is important for Ca2+-dependent 
ALIX-TSG101 complex formation and that depletion of 
ALG-2 by RNA interference (RNAi) abolished the interac-
tion [59]. Moreover, exogenous expression of a wild-type 
ALG-2 construct could restore the Ca2+-dependent ALIX- 
TSG101 interaction in endogenous ALG-2-depleted cells, 
but constructs of a dimerization-defective mutant (Y180A 
substitution) and a shorter isoform ALG-2∆GF122 could not. 
We propose that a Ca2+-loaded dimeric form of ALG-2 sta-
bilizes the complex between ALIX and TSG101 and func-
tions as a Ca2+-adaptor protein as in the case of Figure 7A. 
ALIX directly associates with TSG101 through a weak in-
teraction between the PSAP sequence in ALIX and the 
UEV domain of TSG101, and this complex is stabilized by 
the Ca2+-bound ALG-2 dimer, which binds to the Pro-rich 
regions of the respective target proteins.  
4.3  Function of ALG-2 in ER-to-Golgi transport system 
By staining with antibodies of cytoplasmic marker proteins, 
ALG-2 was found to partially colocalized with Sec31A, a 
component of COPII, in a punctate pattern at endoplasmic 
reticulum (ER) exit sites [44,60]. Live-cell time-lapse im-
aging revealed that fluorescent protein-fused ALG-2 is re-
cruited to ER exit sites in accordance with Ca2+ oscillation 
triggered by a Ca2+-mobilization reagent such as histamine 
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[43,61]. Furthermore, fluorescence recovery after photo-
bleaching (FRAP) analysis indicated that deletion of 
ALG-2-binding site in Sec31A (amino acid residues 839- 
851) reduced the high-affinity (slower dissociation) popula-
tion of Sec31A at the ER exit sites, suggesting that the ca-
pability of ALG-2 binding is one of the key determinants of 
the retention kinetics of Sec31A at ER exit sites [43]. 
ALG-2 and calcium ions inhibit COPII vesicle fusions [62]. 
Recently, we have found that annexin A11, a Ca2+/phos- 
pholipid-binding protein, is involved in this ER-to-Golgi 
transport pathway and that ALG-2 bridges Sec31A and an-
nexin A11 at ER exit sites [63].  
5  Physiological functions of ALG-2 
Regardless of the original cloning report of ALG-2 cDNA 
in a screen for genes involved in cell death [11], ALG-2- 
deficient mice generated by the same group showed no ab-
normality in development and immune functions [64]. Nev-
ertheless, ALG-2 has been suggested to work in cell death 
during ER stress [65]. ALIX and ALG-2 appear to work in 
K+-deprived neuronal cells [66], and they interact directly or 
indirectly with the TNFα receptor-1 (TNF-R1) signaling 
complex [67]. Høj et al. [68] reported that ALG-2 was re-
quired for normal cell division because deficiency of 
ALG-2 by the RNA interference method resulted in G2/M 
cell cycle phase accumulation and cell death. ALG-2 has 
been suggested to be involved in cancer [69]. However, a 
cause-effect relationship is not clear. The gene of ALG-2 
(PDCD6, chromosomal locus at 5p15.33) is a potential 
prognostic marker for malignant progression in pulmonary 
adenocarcinoma with bronchioloalveolar features, and pa-
tients with high expression levels of PDCD6 have low sur-
vival rates [70]. By contrast, low expression level of 
PDCD6 is correlated with poor overall survival of gastric 
cancer patients [71]. Since malfunction of MVB sorting and 
ER-to-Golgi transport affects normal cell growth, dysregu-
lation of the delicate balance between proliferation and cell 
death may lead to malignant progression of tumors.  
6  Conclusion 
EF-hand proteins have similar helix-loop-helix structures, 
but conformational states with respect to angles and dis-
tances between the two helices and their changes in re-
sponse to Ca2+ binding are very diverse [72]. In the case of 
calmodulin, each pair of EF1-EF2 (N-lobe) and EF3-EF4 
(C-lobe) changes its conformation from “closed” to “open” 
state upon Ca2+ binding and exhibits a further gross change 
in relative stereotypic position by bending of the central 
helix connecting EF2 and EF3 in such a way that the two 
lobes grab the targeting peptide [73]. On the other hand, 
ALG-2 does not exhibit a significant change from the  
closed conformational state in the absence of Ca2+ to the 
open conformational state in the presence of Ca2+. Never-
theless, binding of Ca2+ or Zn2+ to EF3 causes a small shift 
of α5 and leads to change in configuration of the R125 side 
chain to move sufficiently for making a primary hydropho-
bic pocket accessible to the critical PPYP motif found in 
ALIX. This novel Ca2+/EF3-driven arginine switch mecha-
nism explains how ALG-2 is activated by Ca2+ to bind to its 
target proteins of at least ABM-1 type proteins.  
There has been a gradual annual increase in the number 
of published articles on ALG-2-interacting proteins. Like 
calmodulin, ALG-2 may interact with various proteins con-
taining flexible recognition motifs with different affinities. 
Data in the genome-wide protein-protein-network (interac-
tome) database obtained by yeast two-hybrid and mass 
spectrometric analyses of affinity-captured proteins are 
helpful for inferring physiological functions of ALG-2. 
However, elimination of false-positive interactions by care-
ful assessment is crucial to avoid misleading to a wrong 
direction of research. We propose a new concept of ALG-2: 
a Ca2+-dependent adaptor. Among the interacting proteins, it 
is necessary to investigate in which combinations ALG-2 
works as an adaptor. Co-localization seems one of the key 
points for evaluating physiologically important partners. In 
certain cases, ALG-2 may promote oligomerization of in-
teracting proteins. Although detection of interactions of 
endogenous proteins with antibodies is the best way to val-
idate physical interactions, a scarce protein may not be de-
tectable. It is possible that as-yet-unidentified ALG-2-  
interacting proteins with high affinity and low abundance, 
rather than already reported proteins reviewed in this article, 
play critical roles in cell functions. However, weak binding 
does not necessarily mean that the interaction is unphysio-
logical. Greater rates of dissociation as well as association 
make it possible to respond more rapidly to the oscillating 
Ca2+ concentration levels.  
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